Moderna Inc. requests authorization for COVID-19 vaccine
Moderna Inc. requests authorization of emergency use for the coronavirus (COVID-19) vaccine with regulators in the U.S. and Europe. This request follows the exciting and promising results of the COVID-19 vaccine trials proving 94% effective in the final analysis of the Phase 3 trial.
Moderna’s Phase 3 trial included nearly 30,000 volunteers with 196 patients developing COVID-19 but a majority of these cases were observed in the placebo group. These promising results were the final step Moderna needed before applying for emergency use of the COVID-19 vaccine with U.S. and European regulators.
BREAKING NEWS: Moderna to file for emergency FDA approval in the race for a vaccine. https://t.co/iplMX9Br3V pic.twitter.com/0kGIy0APxR
— Good Morning America (@GMA) November 30, 2020
The Moderna vaccine will be available in shot form and the study results prove that this vaccine offers strong protection against COVID-19. Moderna is the third pharmaceutical company to apply for emergency vaccine use with Pfizer and BioNTech applying for emergency use on Nov. 20 in the U.S. as well as the UK who is also assessing the AstraZeneca vaccine.
The next step of the FDA approval process is to hold a public debate with scientific advisors on the evidence of each participating candidate for the study. Once approved, Moderna expects to have 20 million doses ready for the U.S. by the end of 2020 with recipients will need two doses and will ultimately provide enough for 10 million patients.
The manufacturing process has already begun and Moderna is ready to start sending out shipments of the vaccine within 24 hours of FDA clearance. A separate panel of U.S. experts designated by the Center for Disease Control and Prevention (CDC) will create a strategy for the distribution of who will receive the initial supplies first.
The initial distribution plan will reserve some doses for health care workers, then the elderly and long-term care facility residents. If everything goes according to plan and the vaccine is approved, Moderna Inc. will be able to provide enough of the vaccine for the general public by Spring 2021.
Simple Snacks For The Keto Diet
-
In a significant escalation of the ongoing dispute over misinformation, Brazil Supreme Court Justice Alexandre de Moraes has initiated...
-
Mumbai Takes the Throne for the Most Billionaires in Asia In a historic milestone, Mumbai has overtaken Beijing to...
-
French President Emmanuel Macron emphasized the need for Western powers to remain vigilant in the face of the Ukraine...
-
The Philippines has strongly denounced what it described as “unprovoked acts of coercion and dangerous maneuvers” by China in...
-
As Moscow Prepares to Bid Adieu, Navalny’s Funeral Raises Uncertainties and International Allegations The spokesperson for Alexei Navalny has...
-
On the two-year anniversary of the ongoing conflict between Ukraine and Russia, there is much to reflect upon. Since...
-
The Office for National Statistics (ONS) released official figures on Wednesday, revealing that the United Kingdom posted a record...
-
Greece has become the first Christian Orthodox-majority country to legalize same-sex marriage, marking a significant step forward for LGBTQ+...
-
Massive Deflation in China as CPI Plummets by 0.8% China faces mounting challenges as its consumer prices spiral deeper...
-
3 Days of Consecutive Snowing Has Wreaked Havoc on Transportation As China prepares to celebrate the Lunar New Year,...
-
Rapid Growth in Electric Cars Propels China to The Forefront of Global Vehicle Exports China has surpassed Japan as...
-
Pakistan’s Political Landscape Suffers a Shift Following Khan’s Sentencing Former Pakistani Prime Minister Imran Khan and his wife, Bushra...